PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 261 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,119 | -42.2% | 29,116 | -8.0% | 0.01% | -33.3% |
| Q2 2023 | $420,985 | +14.9% | 31,653 | +0.0% | 0.02% | +7.1% |
| Q1 2023 | $366,403 | -28.4% | 31,641 | -49.4% | 0.01% | -33.3% |
| Q4 2022 | $511,667 | +41.0% | 62,551 | -0.2% | 0.02% | +31.2% |
| Q3 2022 | $363,000 | +13.4% | 62,671 | -13.6% | 0.02% | +14.3% |
| Q2 2022 | $320,000 | -54.1% | 72,573 | -5.3% | 0.01% | -50.0% |
| Q1 2022 | $697,000 | -46.6% | 76,669 | +20.2% | 0.03% | -58.2% |
| Q4 2021 | $1,305,000 | -78.1% | 63,802 | -62.5% | 0.07% | -77.5% |
| Q2 2021 | $5,955,531 | +5.4% | 170,304 | +0.4% | 0.30% | -8.0% |
| Q1 2021 | $5,652,540 | +58.4% | 169,695 | +23.3% | 0.32% | +37.9% |
| Q4 2020 | $3,569,552 | +193.0% | 137,608 | +11.5% | 0.24% | +139.8% |
| Q3 2020 | $1,218,442 | – | 123,449 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |